Targeted alpha therapy as a new therapeutic strategy for treating metastatic melanoma. (IMAGE)

Chiba University

Targeted alpha therapy as a new therapeutic strategy for treating metastatic melanoma.

Caption

A newly developed astatine-211 (211At)-labeled peptide drug inhibits malignant melanoma cells by releasing alpha particles in the targeted cancer tissue.

Credit

Dr. Hiroyuki Suzuki from Chiba University, Japan

Usage Restrictions

Cannot be used without permission.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.